The current institutional shareholding score of Lexicon Pharmaceuticals Inc is 5.00, ranking 133 out of 388 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 67.79%, representing a quarter-over-quarter decrease of 1.30%. The largest institutional shareholder is Steven Cohen, holding a total of 5.62M shares, representing 1.84% of shares outstanding, with 4.59% increase in holdings.